Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2006-09-26
2006-09-26
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C514S243000
Reexamination Certificate
active
07112675
ABSTRACT:
The present invention provides compounds of formula Iand pharmaceutically acceptable salts thereof.The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1, PDGFR, HER-1, HER-2, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
REFERENCES:
patent: 4908056 (1990-03-01), Tseng
patent: 5686457 (1997-11-01), Traxler et al.
patent: 6787545 (2004-09-01), Ohtani et al.
patent: 2003/0069244 (2003-04-01), Leftheris et al.
patent: 778 277 (1997-06-01), None
patent: 0 795 556 (1997-09-01), None
patent: WO 98/08847 (1998-03-01), None
patent: WO 01/14378 (2001-03-01), None
Patil et al., Journal of Heterocyclic Chemistry 31(4), 781-786, 1994.
Ewald, H., et al. “Reactionen von 1,2,4-Triazinen mit Acetylendlcarbonsaure-dimethylester”, Justus Liebigs Annalen Der Chemie, (1977), vol. 10, pp 1718-1724.
Otter et al., Nucleoside & Nucleotides, 15(1-3), 793-807 (1996).
Quintela et al., Tetrahedron 52(8), 3037-3048 (1996).
Patil et al., J. Heterocyclic Chem., 31(4), 781-807 (1994).
Neunhoeffer et al., Justus Liebigs Ann. Chem., vol. 9, 1413-1420 (1977) & Chem Abstr. 88:121113q, (Apr. 1978).
Skobe et al. Nature Medicine, vol. 3, No. 11, 1223-1227 (Nov. 1997).
Bhide Rajeev S.
Borzilleri Robert Michael
Hunt John T.
Qian Ligang
Balasubramanian Venkataraman
Bristol--Myers Squibb Company
Korsen Elliott
LandOfFree
Pyrrolotriazine inhibitors of kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolotriazine inhibitors of kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolotriazine inhibitors of kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3549984